Home » Topics » Regulatory

Regulatory
RSS

Pravachol now available in Canada for preventing a first heart attack

Oct. 29, 1997

FDA clears generic estradiol product

Oct. 29, 1997

Cangene to manufacture new formulation of NABI's H-BIG

Oct. 28, 1997

Effexor XR cleared by FDA

Oct. 28, 1997

Encouraging preliminary results for finasteride in androgenic alopecia

Oct. 23, 1997

Lower dose version of Caverject introduced

Oct. 23, 1997

Oxis Turbuhaler launched in U.K.

Oct. 23, 1997

Trazodone evaluated in patients with erectile dysfunction

Oct. 23, 1997

FDA clears Dermagraft-TC for new indication

Oct. 23, 1997

Biovail and Technilab Pharma sign marketing agreement

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...